October 04, 2007 07:15 ET

REMINDER: OR-Live Presents: Cardiovascular Webcast: Cardiovascular Specialists at Children's Hospital Boston to Perform Rare Interventional Catheterization During Live Webcast

Live Webcast: From Children's Hospital Boston: October 4, 2007 9:00 AM EDT (13:00 UTC)

BOSTON, MA--(Marketwire - October 4, 2007) - On Thursday, Oct. 4, at 9 a.m. ET, cardiovascular specialists at Children's Hospital Boston will perform a rare interventional catheterization during a live Webcast on Children's hosts three to four Webcasts annually to showcase its pioneering care and technology to specialists and referring clinicians around the world, and to educate consumers on the latest and most innovative medical treatments available.

The Webcast will feature a Transcatheter Pulmonary Valve (TPV) implantation, currently in clinical trial at Children's and two other pediatric hospitals. The non-surgical treatment restores effective pulmonary valve function and potentially prolongs the functional life of the right ventricle to pulmonary artery conduits. Medtronic, Inc. (NYSE: MDT), producer of the valve, is sponsoring the study.

"The trial implants we've conducted have shown positive results -- both clinically and from a quality of life perspective -- for the patient by delaying the need for an invasive open heart procedure to restore valve function," says James E. Lock, MD, cardiologist-in-chief at Children's Hospital Boston and Alexander S. Nadas Professor of Pediatrics at Harvard Medical School. Dr. Lock will perform the procedure for the live Webcast.

Cardiologists Peter Lang, MD, director of Clinical Training Program, and Doff McElhinney, MD, will serve as Webcast commentators, providing additional information about the procedure throughout the hour-long event.

This is the first of two Webcasts featured as part of this year's "Frontiers in Diagnosis & Management of Congenital Heart Disease," taking place at Children's Hospital Boston.

The second Webcast, on Friday, Oct. 5, at 1 p.m. ET, will highlight the repair of a rare congenital cardiac defect by Children's cardiovascular surgeons.

The Conference will focus on review of catheter-based and surgical treatment options for congenital heart disease, as well as current developments in intensive care management and cardiac surgery research.

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including eight members of the National Academy of Sciences, 11 members of the Institute of Medicine and 10 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 377-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit:

Medtronic, Inc. (, headquartered in Minneapolis, is the global leader in medical technology -- alleviating pain, restoring health, and extending life for millions of people around the world.

Visit: now to learn more and view a program preview. VNR:

Contact Information